Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep738 | Pituitary and Neuroendocrinology | ECE2023

Pituitary macroadenoma, incidental finding after soccer match

Valles Cristina Serrano , Sanchez Higinio Ortega , Pascual Cristina Contreras , Rosas Karol Almendra Alvarado

Introduction: Thyrotropin-secreting pituitary tumors (TSH-omas) are a rare disorder and an infrequent cause of hyperthyroidism. The prevalence in the general population being 1 to 2 cases per million. However, recents studies have demonstrated an increase of TSH-omas over time. The increased number of cases principally results from the ultrasensitive TSH immunometric assays and from improved general practioner endocrinologist awaress. There is an inappropriate secretion of TSH...

ea0063p1061 | Pituitary and Neuroendocrinology 3 | ECE2019

Clinical features and endocrine evaluation of non-functioning pituitary adenomas at a secondary level hospital

Pascual Cristina Contreras , Lazaro Paloma Gonzalez , Fernandez Julia Silva , del Val Zaballos Florentino , Alfonso Francisco Javier Gomez , Agredos Alvaro Garcia-Manzanares Vazquez-de , Garcia Ines Rosa Gomez

Introduction: Non-functioning pituitary adenomas are relatively common. A large number of these tumors are asintomathic pituitary microadenomas, that are increasingly detected because of sensitive imaging techniques improves. Those tumors that require treatment are generally macroadenomas and come to medical attention because of mass effect (visual field defects, headache, …) and/or hypopituitarism.Objective: To assess non-functioning pituitary ade...

ea0063gp209 | Diabetes: Pharmacotherapy | ECE2019

Efficacy and tolerability of dulaglutide in patients with type 2 diabetes: Experience on a secondary Hospital

Lazaro Paloma Gonzalez , Pascual Cristina Contreras , del Val Zaballos Florentino , Fernandez Julia Silva , Alfonso Francisco Javier Gomez , Arroyo Belvis Torres , de Agredos Alvaro Garcia Manzanares Vazquez , Garcia Ines Gomez

Introduction: Dulaglutide (Trulicity®) is a long-acting GLP-1 agonist that received US Food and Drug Administration (FDA) approval in 2014. Dulaglutide is a large sized molecule, which limits its renal clearance. This allows for once weekly dosing; which might improve patient compliance significantly. Extensive Phase III study data have been published with regard to dulaglutide, much of which was part of the AWARD studies, which provide evidence for its use in ...

ea0063ep122 | Reproductive Endocrinology | ECE2019

Severe pulmonary tromboembolism and klinefelter syndrome

Fernandez Julia Silva , Zalvide Alberto Escalera , Alfonso Francisco Javier Gomez , Zaballos Florentino Del Val , Arroyo Belvis Torres , Lazaro Paloma Gonzalez , Pascual Cristina Contreras , Mendez Cristina Montalban , Manzanares Alvaro Garcia , Garcia Ines Gomez

Introduction: Klinefelter syndrome (KS) is the most common congenital abnormality causing primary hypogonadism. KS has a tendency for hypercoagulability.Case report: A 48 year old man diagnosed as having KS during the sterility test was admitted to our hospital emergency department after suffering a syncopal episode at work. He complained of difficulty breathing during the last two weeks and he was receiving bronchodilator therapy. He had suffered deep v...

ea0073aep381 | Endocrine-Related Cancer | ECE2021

Case report: Secondary adrenal insufficiency and primary hypothyroidism following Nivolumab therapy in a patient with metastatic melanoma

Paloma González Lázaro , Tirado Antonio Moreno , Pascual Cristina Contreras , Mendez Cristina Montalban , María Zhao Montero Benítez , Inés Gómez García

IntroductionIn recent years, we have observed significant progress in cancer treatment associated with the development of immunotherapy. Nivolumab, an anti-PD-1 antibody, blocks the interaction between PD-1 and its ligands and inhibits the signaling pathway by preventing the tumor-derived PD-L1 from blocking T lymphocytes. In patients with metastatic melanoma, it is used either in monotherapy or in combination with other drugs. Immunotherapy is associate...

ea0073aep454 | General Endocrinology | ECE2021

Acute pancreatitis in a covid-19 patient

Maria Zhao Montero Benítez , Pascual Cristina Contreras , Mendez Cristina Montalban , Tirado Antonio Moreno , Paloma González Lázaro , Florentino Del Val Zaballos , Julia Silva-Fernández , Meneses Amparo Lomas , Francisco Javier Gómez Alfonso , Inés Gómez García

Acute pancreatitis (AP) is an inflammatory disorder of the pancreas, most commonly caused by gallstones and heavy alcohol consumption. The diagnosis is established with at least 2 of the following criteria: abdominal pain; increased serum lipase/amylase levels greater than 3 times the upper limit of normal value; or characteristic findings on contrast computed tomography (CT). Since the beginning of the severe acute respiratory syndrome coronavirus (SARS-CoV-2) pandemic, a few...